HIV-1 Tat upregulates expression of histone deacetylase-2 (HDAC2) in human neurons: Implication for HIV-associated neurocognitive disorder (HAND)

Neurochemistry International

Volumn 58, Issue 6, 2011, Pages 656-664

  Saiyed, Zainulabedin M ^a   Gandhi, Nimisha ^a   Agudelo, Marisela ^a   Napuri, Jessica ^a   Samikkannu, Thangavel ^a   Reddy, Pichili V B ^a   Khatavkar, Pradnya ^a   Yndart, Adriana ^a   Saxena, Shailendra K ^b   Nair, Madhavan P N ^a  

^a FLORIDA INTERNATIONAL UNIVERSITY   (United States)

^b CENTRE FOR CELLULAR AND MOLECULAR BIOLOGY   (India)

Author keywords

Histone deacetylases; HIV associated neurocognitive disorder; Primary human neurons; SK N MC neuroblastoma cell line; Synaptic plasticity; Tat protein

Indexed keywords

HISTONE DEACETYLASE 2; TRANSACTIVATOR PROTEIN;

ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DOSE RESPONSE; DOWN REGULATION; ENZYME INHIBITION; GENE CONTROL; GENE REPRESSION; HIV ASSOCIATED DEMENTIA; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; NERVE CELL; NERVE CELL PLASTICITY; NERVE FUNCTION; NEUROBLASTOMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

AIDS DEMENTIA COMPLEX; CELL LINE, TUMOR; FLOW CYTOMETRY; GENE PRODUCTS, TAT; HISTONE DEACETYLASE 2; HIV-1; HUMANS; HYDROXAMIC ACIDS; NEURONS; POLYMERASE CHAIN REACTION; UP-REGULATION;

HUMAN IMMUNODEFICIENCY VIRUS 1; MUS;

EID: 79953680722     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2011.02.004     Document Type: Article

References (49)

1. M.W. Akhtar, J. Raingo, E.D. Nelson, R.L. Montgomery, E.N. Olson, E.T. Kavalali, and L.M. Monteggia Histone deacetylases 1 and 2 form a developmental switch that controls excitatory synapse maturation and function J. Neurosci. 29 2009 8288 8297
2. E.R. Anderson, J. Boyle, W.E. Zink, Y. Persidsky, H.E. Gendelman, and H. Xiong Hippocampal synaptic dysfunction in a murine model of human immunodeficiency virus type 1 encephalitis Neuroscience 118 2003 359 369 (Pubitemid 36423251)
3. A. Antinori, G. Arendt, J.T. Becker, B.J. Brew, D.A. Byrd, M. Cherner, D.B. Clifford, P. Cinque, L.G. Epstein, K. Goodkin, M. Gisslen, I. Grant, R.K. Heaton, J. Joseph, K. Marder, C.M. Marra, J.C. McArthur, M. Nunn, R.W. Price, L. Pulliam, K.R. Robertson, N. Sacktor, V. Valcour, and V.E. Wojna Updated research nosology for HIV-associated neurocognitive disorders Neurology 69 2007 1789 1799 (Pubitemid 350059308)
4. N.M. Archin, A. Espeseth, D. Parker, M. Cheema, D. Hazuda, and D.M. Margolis Expression of latent HIV induced by the potent HDAC inhibitor suberoylanilide hydroxamic acid AIDS Res. Hum. Retroviruses 25 2009 207 212
5. R. Butler, and G.P. Bates Histone deacetylase inhibitors as therapeutics for polyglutamine disorders Nat. Rev. Neurosci. 7 2006 784 796 (Pubitemid 44435261)
6. D.M. Chuang, Y. Leng, Z. Marinova, H.J. Kim, and C.T. Chiu Multiple roles of HDAC inhibition in neurodegenerative conditions Trends Neurosci. 32 2009 591 601
7. J.R. Davie, and V.A. Spencer Control of histone modifications J. Cell. Biochem. 32-33 Suppl. 1999 141 148 (Pubitemid 30041820)
8. R. Easley, R. Van Duyne, W. Coley, I. Guendel, S. Dadgar, K. Kehn-Hall, and F. Kashanchi Chromatin dynamics associated with HIV-1 Tat-activated transcription Biochim. Biophys. Acta 1799 2010 275 285
9. R. Ellis, D. Langford, and E. Masliah HIV and antiretroviral therapy in the brain: neuronal injury and repair Nat. Rev. Neurosci. 8 2007 33 44 (Pubitemid 46011997)
10. A. Fischer, F. Sananbenesi, X. Wang, M. Dobbin, and L.H. Tsai Recovery of learning and memory is associated with chromatin remodelling Nature 447 2007 178 182 (Pubitemid 46763080)
11. B.B. Gelman, V.M. Soukup, K.W. Schuenke, M.J. Keherly, C. Holzer 3rd, F.J. Richey, and C.J. Lahart Acquired neuronal channelopathies in HIV-associated dementia J. Neuroimmunol. 157 2004 111 119 (Pubitemid 39576644)
12. M. Gersten, M. Alirezaei, M.C. Marcondes, C. Flynn, T. Ravasi, T. Ideker, and H.S. Fox An integrated systems analysis implicates EGR1 downregulation in simian immunodeficiency virus encephalitis-induced neural dysfunction J. Neurosci. 29 2009 12467 12476
13. J.S. Guan, S.J. Haggarty, E. Giacometti, J.H. Dannenberg, N. Joseph, J. Gao, T.J. Nieland, Y. Zhou, X. Wang, R. Mazitschek, J.E. Bradner, R.A. DePinho, R. Jaenisch, and L.H. Tsai HDAC2 negatively regulates memory formation and synaptic plasticity Nature 459 2009 55 60
14. R.G. Gupta, K.M. Kelly, K.L. Helke, S.E. Queen, J.M. Karper, J.L. Dorsey, A.K. Brice, R.J. Adams, P.M. Tarwater, D.L. Kolson, and J.L. Mankowski HIV and SIV induce alterations in CNS CaMKII expression and activation: a potential mechanism for cognitive impairment Am. J. Pathol. 176 2010 2776 2784
15. K. Hayashi, H. Pu, I.E. Andras, S.Y. Eum, A. Yamauchi, B. Hennig, and M. Toborek HIV-TAT protein upregulates expression of multidrug resistance protein 1 in the blood-brain barrier J. Cereb. Blood Flow Metab. 26 2006 1052 1065 (Pubitemid 44134076)
16. C. Hildmann, D. Riester, and A. Schwienhorst Histone deacetylases - an important class of cellular regulators with a variety of functions Appl. Microbiol. Biotechnol. 75 2007 487 497 (Pubitemid 46776553)
17. L. Host, J.B. Dietrich, D. Carouge, D. Aunis, and J. Zwiller Cocaine self-administration alters the expression of chromatin-remodelling proteins; modulation by histone deacetylase inhibition J. Psychopharmacol. 2009 10.1177/0269881109348173 (Epub ahead of print)
18. T. Ikezu The aging of human-immunodeficiency-virus-associated neurocognitive disorders J. Neuroimmune Pharmacol. 4 2009 161 162
19. G.D. Kanmogne, K. Schall, J. Leibhart, B. Knipe, H.E. Gendelman, and Y. Persidsky HIV-1 gp120 compromises blood-brain barrier integrity and enhances monocyte migration across blood-brain barrier: Implication for viral neuropathogenesis J. Cereb. Blood Flow Metab. 27 2007 123 134 (Pubitemid 46006590)
20. A.G. Kazantsev, and L.M. Thompson Therapeutic application of histone deacetylase inhibitors for central nervous system disorders Nat. Rev. Drug Discov. 7 2008 854 868
21. K.S. Keedy, N.M. Archin, A.T. Gates, A. Espeseth, D.J. Hazuda, and D.M. Margolis A limited group of class I histone deacetylases acts to repress human immunodeficiency virus type 1 expression J. Virol. 83 2009 4749 4756
22. O.H. Kramer HDAC2: a critical factor in health and disease Trends Pharmacol. Sci. 30 2009 647 655
23. I.I. Kruman, A. Nath, and M.P. Mattson HIV-1 protein Tat induces apoptosis of hippocampal neurons by a mechanism involving caspase activation, calcium overload, and oxidative stress Exp. Neurol. 154 1998 276 288 (Pubitemid 29044201)
24. B. Langley, J.M. Gensert, M.F. Beal, and R.R. Ratan Remodeling chromatin and stress resistance in the central nervous system: Histone deacetylase inhibitors as novel and broadly effective neuroprotective agents Curr. Drug Targets CNS Neurol. Disord. 4 2005 41 50 (Pubitemid 41403313)
25. J.M. Levenson, K.J. O'Riordan, K.D. Brown, M.A. Trinh, D.L. Molfese, and J.D. Sweatt Regulation of histone acetylation during memory formation in the hippocampus J. Biol. Chem. 279 2004 40545 40559 (Pubitemid 39287646)
26. W. Li, Y. Huang, R. Reid, J. Steiner, T. Malpica-Llanos, T.A. Darden, S.K. Shankar, A. Mahadevan, P. Satishchandra, and A. Nath NMDA receptor activation by HIV-tat protein is clade dependent J. Neurosci. 28 2008 12190 12198
27. X. Li, Y. Kato, Y. Tsuji, and Y. Tsunoda The effects of trichostatin A on mRNA expression of chromatin structure-DNA methylation-, and development-related genes in cloned mouse blastocysts Cloning Stem Cells 10 1 2008 133 142 (Pubitemid 351341549)
28. J. Lisman, H. Schulman, and H. Cline The molecular basis of CaMKII function in synaptic and behavioural memory Nat. Rev. Neurosci. 3 2002 175 190 (Pubitemid 135706588)
29. P.M. Maki, M.H. Cohen, K. Weber, D.M. Little, D. Fornelli, L.H. Rubin, P. Perschler, F. Gould, and E. Martin Impairments in memory and hippocampal function in HIV-positive vs. HIV-negative women Neurology 72 2009 1661 1668
30. D.M. Margolis Histone deacetylases inhibitors and HIV latency Curr. Opin. HIV AIDS 6 2010 25 29
31. E. Masliah, N. Ge, C.L. Achim, L.A. Hansen, and C.A. Wiley Selective neuronal vulnerability in HIV encephalitis J. Neuropathol. Exp. Neurol. 51 1992 585 593
32. J.C. McArthur, and B.J. Brew HIV-associated neurocognitive disorders: is there a hidden epidemic? AIDS 24 2010 1367 1370
33. M. Mishra, S. Vetrivel, N.B. Siddappa, U. Ranga, and P. Seth Clade-specific differences in neurotoxicity of human immunodeficiency virus-1 B and C tat of human neurons: significance of dicysteine C30C31 motif Ann. Neurol. 63 2008 366 376 (Pubitemid 351499866)
34. A. Nath, N.J. Haughey, M. Jones, C. Anderson, J.E. Bell, and J.D. Geiger Synergistic neurotoxicity by human immunodeficiency virus proteins Tat and gp120: protection by memantine Ann. Neurol. 47 2000 186 194 (Pubitemid 30078565)
35. A. Nath, K. Psooy, C. Martin, B. Knudsen, D.S. Magnuson, N. Haughey, and J.D. Geiger Identification of a human immunodeficiency virus type 1 Tat epitope that is neuroexcitatory and neurotoxic J. Virol. 70 1996 1475 1480 (Pubitemid 26062905)
36. S.W. Perry, J. Barbieri, N. Tong, O. Polesskaya, S. Pudasaini, A. Stout, R. Lu, M. Kiebala, S.B. Maggirwar, and H.A. Gelbard Human immunodeficiency virus-1 tat activates calpain proteases via the ryanodine receptor to enhance surface dopamine transporter levels and increase transporter-specific uptake and vmax J. Neurosci. 30 2010 14153 14164
37. Y. Persidsky, and H.E. Gendelman Mononuclear phagocyte immunity and the neuropathogenesis of HIV-1 infection J. Leukoc. Biol. 74 2003 691 701 (Pubitemid 38040345)
38. D.D. Richman, D.M. Margolis, M. Delaney, W.C. Greene, D. Hazuda, and R.J. Pomerantz The challenge of finding a cure for HIV infection Science 323 2009 1304 1307
39. B. Shi, J. Raina, A. Lorenzo, J. Busciglio, and D. Gabuzda Neuronal apoptosis induced by HIV-1 Tat protein and TNF-a: potentiation of neurotoxicity mediated by oxidative stress and implications for HIV-1 dementia J. Neurovirol. 4 1998 281 290 (Pubitemid 28260712)
40. A.J. Silva, C.F. Stevens, S. Tonegawa, and Y. Wang Deficient hippocampal long-term potentiation in alpha-calcium-calmodulin kinase II mutant mice Science 257 1992 201 206
41. J.C. Stout, D.P. Salmon, N. Butters, M. Taylor, G. Peavy, W.C. Heindel, D.C. Delis, L. Ryan, J.H. Atkinson, and J.L. Chandler Decline in working memory associated with HIV infection HNRC group Psychol. Med. 25 1995 1221 1232
42. J.M. Sun, V.A. Spencer, H.Y. Chen, L. Li, and J.R. Davie Measurement of histone acetyltransferase and histone deacetylase activities and kinetics of histone acetylation Methods 31 2003 12 23 (Pubitemid 36945166)
43. E.A. Thomas Focal nature of neurological disorders necessitates isotype-selective histone deacetylase (HDAC) inhibitors Mol. Neurobiol. 40 2009 33 45
44. M. Toborek, Y.W. Lee, G. Flora, H. Pu, I.E. Andras, E. Wylegala, B. Hennig, and A. Nath Mechanisms of the blood-brain barrier disruption in HIV-1 infection Cell. Mol. Neurobiol. 25 2005 181 199 (Pubitemid 40558590)
45. C.G. Vecsey, J.D. Hawk, K.M. Lattal, J.M. Stein, S.A. Fabian, M.A. Attner, S.M. Cabrera, C.B. McDonough, P.K. Brindle, T. Abel, and M.A. Wood Histone deacetylase inhibitors enhance memory and synaptic plasticity via CREB:CBP-dependent transcriptional activation J. Neurosci. 27 2007 6128 6140 (Pubitemid 46890024)
46. S.P. Woods, D.J. Moore, E. Weber, and I. Grant Cognitive neuropsychology of HIV-associated neurocognitive disorders Neuropsychol. Rev. 19 2009 152 168
47. H. Xiao, C. Neuveut, H.L. Tiffany, M. Benkirane, E.A. Rich, P.M. Murphy, and K.T. Jeang Selective CXCR4 antagonism by tat: implications for in vivo expansion of coreceptor use by HIV-1 Proc. Natl. Acad. Sci. U.S.A. 97 2000 11466 11471
48. L. Ylisastigui, N.M. Archin, G. Lehrman, R.J. Bosch, and D.M. Margolis Coaxing HIV-1 from resting CD4 T cells: histone deacetylase inhibition allows latent viral expression AIDS 18 2004 1101 1108 (Pubitemid 38738509)
49. G. Zauli, D. Milani, P. Mirandola, M. Mazzoni, P. Secchiero, S. Miscia, and S. Capitani HIV-1 Tat protein down-regulates CREB transcription factor expression in PC12 neuronal cells through a phosphatidylinositol 3-kinase/AKT/cyclic nucleoside phosphodiesterase pathway FASEB J. 15 2001 483 491 (Pubitemid 32141440)